Discover the world’s first Smart Continuous Glucose Monitoring (CGM)* system for people on insulin injections. With breakthrough tools to help outsmart the highs and lows of diabetes, the Guardian™ Connect CGM allows you to focus more on your life—not on your levels.
Available for Apple Devices
The only Smart CGM system that helps you outsmart both highs and lows. Using smart technology to predict where your glucose levels are headed, the system will alert you from 10 to 60 minutes before a high or low.
We’ve designed Guardian™ Connect CGM with value in mind. You don’t need to buy a separate receiver like with other CGM systems3.
|Feature||Why It's Important||Guardian™ Connect System||Other Continuous Glucose Monitoring||Flash Glucose Monitoring|
|Predictive alerts†||So you can make adjustments ahead of time.||§|
|CareLink™ Software||CareLink™ Personal therapy management software automatically uploads Guardian™ Connect CGM data, so you can tailor your treatment plan with your healthcare provider.|
|Caregiver Data Share||The people that are important to supporting your diabetes management receive alerts when it matters most|
|Dedicated Monitor Required at purchase||The Guardian™ Connect system for IOS gives you convenience with no extra device required||4||4|
|Sugar.IQ™ Diabetes Assistant||The Sugar.IQ app uses IBM Watson™ to provide intelligent insights that help you make more informed decisions6|
|StartRightSM||Our specialized onboarding program helps you make a smooth transition to Guardian™ Connect system|
Only the Guardian™ Connect CGM system can link with the Sugar.IQ™ smart diabetes assistant. The Sugar.IQ™ assistant supercharges the Guardian™ Connect system’s smarts by giving you a big picture view of your glucose patterns – and the factors that affect them.
Stay connected to your loved ones with the CareLink™ Connect platform. Anytime access to glucose levels and automatic text message alerts give your loved ones peace of mind.
* Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to Sugar.IQ™ insights that can inform users of clinically relevant glucose patterns.
† At the time of FDA approval of the Guardian Connect System
§ Projected alerts available only with user invention of system scan per Freestyle Libre IFU.
1 Dexcom IFU
2 Guardian Connect IFU
3 With threshold and predictive alerts within the 15 minute period before or after your blood sugar goes below 70 mg/dL.
4 Per system description, a dedicated monitor must be purchased
5 Corriveau EA, Durso PJ, Kaufman ED,et al. Effect of CareLink, aninternet-based insulin pump monitoring system, on glycemiccontrol in rural and urban children with type1 diabetes mellitus. PediatricDiabetes. 2008;9(PartII):360–366.
6The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.
By submitting this form, you are granting Medtronic MiniMed, Inc. ("Medtronic") permission to add your contact information to its database for sending you additional information and communications related to Medtronic products and therapies. You may revoke this permission at any time by e-mailing firstname.lastname@example.org or by sending a request in writing to: Medtronic MiniMed, Inc. c/o Customer Support, 18000 Devonshire Street, Northridge, CA 91325-1219
Important Safety Information: Guardian™ Connect CGM System
The Guardian Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and http://www.medtronicdiabetes.com/importantsafetyinformation.
For proper instructions on inserting the Guardian™ sensor 3, visit the support webpage for inserting your sensor.
With Watson is a trademark of International Business Machines Corporation, registered in many jurisdictions worldwide.
© Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic™. Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.